BAYER AG
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain
- Conditions
- Interventions
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2022-12-12
- Lead Sponsor
- Bayer
- Target Recruit Count
- 154
- Registration Number
- NCT04641273
- Locations
- 🇩🇰
Kolding Sygehus, Kolding, Denmark
🇨🇿NEUROHK s.r.o, Chocen, Czechia
🇨🇿Vestra Clinics s.r.o., Rychnov nad Kneznou, Czechia
A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).
- Conditions
- Interventions
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- Bayer
- Target Recruit Count
- 330
- Registration Number
- NCT04641234
- Locations
- 🇧🇪
Many Locations, Multiple Locations, Belgium
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb
- First Posted Date
- 2020-11-03
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 215
- Registration Number
- NCT04614246
- Locations
- 🇺🇸
Physician Care Clinical Research, Sarasota, Florida, United States
🇺🇸Medisense, Inc., Atlanta, Georgia, United States
🇺🇸HWC Women's Research Center, Englewood, Ohio, United States
Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 16
- Registration Number
- NCT04609943
- Locations
- 🇩🇪
Universitätsklinikum Giessen und Marburg, Gießen, Hessen, Germany
🇩🇪Klinikum der Stadt Köln gGmbH - Krankenhaus Merheim, Köln, Nordrhein-Westfalen, Germany
🇩🇪Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed, Remscheid, Nordrhein-Westfalen, Germany
Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2022-06-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 397
- Registration Number
- NCT04607382
- Locations
- 🇯🇵
Multiple Facilities, Multiple Locations, Japan
A Study to Learn More About What Japanese Patients With Solid Tumors Think About Taking Medicine That is Based on Their Genetic Information
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 605
- Registration Number
- NCT04607889
- Locations
- 🇯🇵
Many locations, Multiple Locations, Japan
A Study to Learn More About the Safety of Ultravist in Children and in the Elderly
- First Posted Date
- 2020-10-28
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 132850
- Registration Number
- NCT04605471
- Locations
- 🇩🇪
Four company sponsored non-interventional studies with iopromide, Berlin, Germany
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH
- Conditions
- Interventions
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Bayer
- Target Recruit Count
- 696
- Registration Number
- NCT04597125
- Locations
- 🇪🇸
Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
🇪🇸Hospital Universitario Puerta del Mar, Cadiz, Andalucía, Spain
🇦🇺Nepean Hospital, Kingswood, Australia
A Study to Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have Not Received Radium-223 Before
- Conditions
- Interventions
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1067
- Registration Number
- NCT04587427
- Locations
- 🇳🇱
Many Locations, Multiple Locations, Netherlands
A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A
- First Posted Date
- 2020-09-25
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 45
- Registration Number
- NCT04565236
- Locations
- 🇨🇳
Shijiazhuang General Hospital, Shijiazhuang, Hebei, China
🇨🇳NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School, Nanjing, Jiangsu, China
🇨🇳1st Affiliated hospital of Soochow University, Suzhou, Jiangsu, China